The proceedings of the Sixth Annual Think Tank recapitulate progress in applications of neurotechnology, neurophysiology and emerging techniques for the treatment of a range of psychiatric and neurological conditions including Parkinson’s disease, essential tremor, Tourette syndrome, epilepsy, cognitive disorders, and addiction.
A research team led by Wissam Deeb, M.D., assistant professor of neurology at the University of Florida, analyzed a phenomenon of flashback-like cognitive experiences in nearly half of the patients occurring during initial programming of the stimulator.
Recently, many people with Parkinson’s disease (PD) have been informed by their pharmacy that there is a shortage of Sinemet or that their brand of Sinemet has been “discontinued.” What should you do?
UF Health has been named one of four Parkinson’s Foundation Research Centers of Excellence.
Fixel Chair Dr. Malu Tansey co-authors a News and Views article in Nature about Infection and Parkinson’s Disease.
Ayse Gunduz PhD, PI of the Brain Mapping laboratory at the Fixel Institute and member of the MBI receives white house recognition for her science
Fixel investigator Daniela Oliveira, PHD, researches how people with neurodegenerative diseases can get caught and more importantly can protect themselves from phishing scams.
Tyler Staab was the first patient seen at the Norman Fixel Institute for Neurological Diseases at UF Health, which opened its doors to the public on July 1, 2019. Tyler’s Hope for a Dystonia Cure has been one of the Fixel Institute and MBI’s biggest supporters over the years.
Steven Dekosky, a Neurologist with the Fixel Institute for Neurological Diseases, explains to the Washington Post what’s known and what isn’t about supplements, nutrition and brain health
On Sept. 1, renowned neurogeneticist Matthew Farrer, Ph.D., internationally recognized for his work on the genetics of Parkinson’s disease, will join UF Health, the University of Florida’s academic health center.